Stroke Clinical Trials in Minneapolis, Minnesota

4 studies are recruiting for stroke in Minneapolis, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

    This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limi…

    Stage
    Phase 2
    Ages
    18 to 90
    Site
    Abbott Northwestern Hospital, Minneapolis, Minnesota
    Locations
    86 in total
    Run by
    DiaMedica Therapeutics Inc

    See if you can join NCT05065216 on ClinicalTrials.gov

  2. GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

    This study will assess the safety and effectiveness of GORE® CARDIOFORM Septal Occluder in a post approval setting and evaluate the quality of operator education and training and transferability of trial experience to a post-market setting.

    Stage
    Not phased
    Ages
    18 to 70
    Site
    Minneapolis Heart Institute Foundation - Abbott Northwestern Hospital, Minneapolis, Minnesota
    Locations
    45 in total
    Run by
    W.L.Gore & Associates

    See if you can join NCT03821129 on ClinicalTrials.gov

  3. Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

    CAPTIVA-MRI is an observational multimodal MR imaging study that is ancillary to the CAPTIVA trial [a 3-arm, double-blind Phase III trial conducted at approximately 115 StrokeNet sites randomizing patients with stroke attributed to 70-99% intracranial atherosclerotic stenosis (ICAS) to aspirin plus…

    Stage
    Not phased
    Ages
    18 and older
    Site
    M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota
    Locations
    28 in total
    Run by
    Yale University

    See if you can join NCT05907629 on ClinicalTrials.gov

  4. Feasibility of a Remotely Delivered Step Count Intervention in Chronic Stroke

    The goal of this study is to explore the feasibility of a new approach to rehabilitation that focuses on step count. Participants will complete 6 telephone or Zoom-based sessions with an occupational therapist over 6 weeks and use a step count tracker during that time. They will also complete quest…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Minnesota, Minneapolis, Minnesota
    Run by
    University of Minnesota

    See if you can join NCT07649135 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.